Fundraising FoxChase Therapeutics
Washington, US · Founded 2017 · Delaware corporation
Find your way into Chase Therapeutics
Sign up to see every warm intro you have to Chase Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chase Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Chase Therapeutics was founded in 2017 by Thomas N. Chase.
TN
Thomas N. ChasePresident and Chief Executive Officer
KC
Kathleen Clarence-SmithNamed on SEC filing
RP
Richard P. DulikSecretary
Funding
SEC filings, press & company announcements$25.3M disclosed across 3 rounds · 2017–2021
- $20MSeries BOct 2021 · 2 sourcesSource ↗
▶$4MraisedAug 2018 · 3 investors · PharmaceuticalsRule 506(b)
▶$4MraisedAug 2018 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard P. DulikExecutive Officer
- Kathleen Clarence-SmithDirector
- Karoly NikolichDirector
- John ReherDirector
- Thomas N. ChaseExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $1
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.3MraisedNov 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedNov 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas N. ChaseExecutive Officer, Director
- Richard P. DulikExecutive Officer
- Kathleen Clarence-SmithDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $1
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Chase Therapeutics?
- Chase Therapeutics was founded by Thomas N. Chase in 2017.
- How much funding has Chase Therapeutics raised?
- Chase Therapeutics has disclosed $25.3M raised across 3 rounds.
- Where is Chase Therapeutics headquartered?
- Chase Therapeutics is headquartered in Washington, US.